• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
XING Xiaoqing, BU Xiumin, CHU Yanan, ZOU Bingjie, SONG Qinxin, ZHOU Guohua. Genotype method for SNPs related to individualized aspirin treatment based on pyrosequencing technology[J]. Journal of China Pharmaceutical University, 2017, 48(5): 577-582. DOI: 10.11665/j.issn.1000-5048.20170512
Citation: XING Xiaoqing, BU Xiumin, CHU Yanan, ZOU Bingjie, SONG Qinxin, ZHOU Guohua. Genotype method for SNPs related to individualized aspirin treatment based on pyrosequencing technology[J]. Journal of China Pharmaceutical University, 2017, 48(5): 577-582. DOI: 10.11665/j.issn.1000-5048.20170512

Genotype method for SNPs related to individualized aspirin treatment based on pyrosequencing technology

More Information
  • There are significant individual differences in the antiplatelet effects of aspirin. Three single nucleotide polymorphisms(SNPs), rs5918, rs12041331 and rs730012, are reported to significantly correlate with the efficacy and side effects of aspirin. In the present study, the genotyping method of the three SNPs was established based on the combination of polymerase chain reaction and pyrosequencing technology. Amplification and sequencing primers were designed independently; the amplification conditions were optimized to amplify the three SNPs in the same condition. The sensitivity of the method was detected using original genome DNA at different concentrations. In order to testify the accuracy of the method, the proposed method and Sanger sequencing technology were both used to genotype the three SNPs in 20 blood samples. The results demonstrated that the genotyping method of aspirin-related SNPs was successfully established, with the detection limit being as low as 0. 4 ng genome DNA. The genotype results of 20 samples by the proposed method were exactly the same as that of Sanger sequencing. It is evident that the proposed method is sensitive and accurate.
  • [1]
    Grinstein J, Cannon CP. Aspirin resistance: current status and role of tailored therapy[J].Clin Cardiol,2012,35(11):673-681.
    [2]
    Pappas JM,Westengard JC,Bull BS.Population variability in the effect of aspirin on platelet function.Implications for clinical trials and therapy[J].Arch Pathol Lab Med,1994,118(8):801-804.
    [3]
    Grotemeyer KH.Effects of acetylsalicylic acid in stroke patients.Evidence of nonresponders in a subpopulation of treated patients[J].Thromb Res,1991,63(6):587-593.
    [4]
    Dharmasaroja PA,Muengtaweepongsa S,Sae-Lim S.Aspirin nonresponders in patients with ischaemic stroke[J].Blood Coagul Fibrinolysis,2013,24(4):361-364.
    [5]
    Blann AD,Kuzniatsova N,Lip GY.Vascular and platelet responses to aspirin in patients with coronary artery disease[J].Eur J Clin Invest,2013,43(1):91-99.
    [6]
    Würtz M,Nissen PH,Grove EL,et al.Genetic determinants of on-aspirin platelet reactivity:focus on the influence of PEAR1[J].PLoS ONE,2014,9(10):e111816.
    [7]
    Floyd CN,Ferro A.The PlA1/A2 polymorphism of glycoprotein IIIa in relation to efficacy of antiplatelet drugs:a systematic review and meta-analysis[J].Br J Clin Pharmacol,2014,77(3):446-457.
    [8]
    Floyd CN,Mustafa A,Ferro A.The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for myocardial infarction:a meta-analysis[J].PLoS ONE,2014,9(7):e101518.
    [9]
    Verdoia M,Cassetti E,Schaffer A,et al.Platelet glycoprotein IIIa Leu33Pro gene polymorphism and coronary artery disease:a meta-analysis of cohort studies[J].Platelets,2015,26(6):530-535.
    [10]
    Verdoia M,Cassetti E,Schaffer A,et al.Relationship between glycoprotein IIIa platelet receptor gene polymorphism and coronary artery disease[J].Angiology,2015,66(1):79-85.
    [11]
    Michelson AD,Furman MI,Goldschmidt-Clermont P,et al.Platelet GP IIIa Pl(A)polymorphisms display different sensitivities to agonists[J].Circulation,2000,101(9):1013-1018.
    [12]
    Lewis JP,Ryan K,O′Connell JR,et al.Genetic variation in PEAR1 is associated with platelet aggregation and cardiovascular outcomes[J].Circ Cardiovasc Gene,2013,6(2):184-192.
    [13]
    Sánchez-Borges M,Acevedo N,Vergara C,et al.The A-444C polymorphism in the leukotriene C4 synthase gene is associated with aspirin-induced urticaria[J].J Investig Allergol Clin Immunol,2009,19(5):375-382.
    [14]
    Kim SH, Ye YM, Lee SK, et al. Genetic mechanism of aspirin-induced urticaria/angioedema[J].Curr Opin Allergy Clin Immunol,2006,6(4):266-270.
    [15]
    Park SM,Park JS,Park HS,et al.Unraveling the genetic basis of aspirin hypersensitivity in asthma beyond arachidonate pathways[J].Allergy Asthma Immunol Res,2013,5(5):258-276.
    [16]
    Jakubowska A,Rozkrut D,Antoniou A,et al.The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks:results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers[J].Breast Cancer Res Treat,2009,121(3):639-649.
    [17]
    Pan W,Byrne-Steele M,Wang C,et al.DNA polymerase preference determines PCR priming efficiency[J].BMC Biotechnol,2014,14:10.
    [18]
    Li XX,Zhao HY,Yang YT,et al.Comparing the three methods to extract human genomic DNA from whole blood[J].Prog Mod Biomed(现代生物医学进展),2013,13(27):5221-5225.
    [19]
    Chu YN,Zhang JY,Feng LY,et al.Establishment of a rapid and inexpensive identification method for HLA-B*58:01 genotype[J].Chin J Anal Chem(分析化学),2016,44(5):693-697.
    [20]
    Zhou G,Song Q.Advances and Clinical Practice in Pyrosequencing[M].New York:Springer,2016:14.
  • Related Articles

    [1]XIE Jing, FAN Chunlin, XU Jie, ZHANG Jian, YE Wencai, ZHANG Xiaoqi. Alkaloids of Ervatamia pandacaqui[J]. Journal of China Pharmaceutical University, 2021, 52(3): 287-292. DOI: 10.11665/j.issn.1000-5048.20210304
    [2]LI Linzhen, WEI Xi, LIU Lu, LI Yongjun, LIANG Jingyu. Chemical constituents from the stems of Clerodendrum trichotomum Thunb.[J]. Journal of China Pharmaceutical University, 2019, 50(5): 544-548. DOI: 10.11665/j.issn.1000-5048.20190506
    [3]LIN Qinghua, XU Jian, FENG Feng. Chemical constituents from the stems of Picrasma quassioides Bennet[J]. Journal of China Pharmaceutical University, 2017, 48(6): 675-679. DOI: 10.11665/j.issn.1000-5048.20170607
    [4]HUANG Qilong, ZHANG Wanjin, LI Yan, CHEN Juan, ZHOU Baoping, ZOU Xiaohan, ZHANG Chunlei, CAO Zhengyu. Alkaloid constituents from Corydalis decumbens[J]. Journal of China Pharmaceutical University, 2017, 48(5): 563-567. DOI: 10.11665/j.issn.1000-5048.20170509
    [5]XU Yunhui, JIANG Xueyang, XU Jian, JIANG Renwang, ZHANG Jie, XIE Zijian, FENG Feng. Chemical constituents from Callicarpa kwangtungensis Chun[J]. Journal of China Pharmaceutical University, 2016, 47(3): 299-302. DOI: 10.11665/j.issn.1000-5048.20160309
    [6]MA Lin, ZHANG Rongfei, YU Shule, WU Zhengfeng, ZHAO Shouxun, Wang Lei, YE Wencai, ZHANG Jian, YIN Zhiqi. Chemical constituents of Fructus Gleditsiae Abnormalis[J]. Journal of China Pharmaceutical University, 2015, 46(2): 188-193. DOI: 10.11665/j.issn.1000-5048.20150209
    [7]LI Linzhen, WANG Menghua, SUN Jianbo, LIANG Jingyu. Chemical constituents from Aletris spicata[J]. Journal of China Pharmaceutical University, 2014, 45(2): 175-177. DOI: 10.11665/j.issn.1000-5048.20140208
    [8]CHANG Bo, XIAO Linjing, ZHANG Jian, ZHAO Shouxun, YE Wencai, YIN Zhiqi. Chemical constituents from Abies ernestii var.salouenensis[J]. Journal of China Pharmaceutical University, 2014, 45(1): 43-47. DOI: 10.11665/j.issn.1000-5048.20140107
    [9]LI Jiu-hui, CHEN Guang-ying, HAN Chang-ri, MO Zheng-rong, SONG Xiao-ping. Chemical constituents from the stems of Vatica mangachpoi Blanco[J]. Journal of China Pharmaceutical University, 2012, 43(1): 25-27.
    [10]Chemical constituents from Senecio nemorensis.[J]. Journal of China Pharmaceutical University, 2010, 41(1): 26-28.

Catalog

    Article views (851) PDF downloads (1608) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return